– HANSIZHUANG ® (serplulimab) a été le premier anticorps monoclonal anti-PD-1 approuvé pour le traitement de première intention du CPPC au stade étendu – HETRONIFLY® (serplulimab) devrait devenir le premier anticorps monoclonal anti-PD-1 disponible en Europe pour le traitement de première…
Month: September 2024
HandicapMD.com, a leader in telehealth services specializing in disability evaluations, is making it easier than ever for New Yorkers to obtain a handicap placard online. HEMPSTEAD, N.Y., Sept. 22, 2024 /PRNewswire/ — With a focus on streamlining the process, HandicapMD.com offers…
HAIKOU, China, Sept. 22, 2024 /PRNewswire/ — A report from Hainan International Media Center (HIMC): On September 21, the 14th China International Digital Publishing Expo opened in Haikou, capital city of south China’s Hainan Province. This year’s Expo focuses on topics such as…
Brookdale is celebrating the power of senior living for health and longevity NASHVILLE, Tenn., Sept. 22, 2024 /PRNewswire/ — Brookdale Senior Living is proud to celebrate National Centenarians Day on September 22 by honoring approximately 750 remarkable residents across the country who…
NEW YORK, Sept. 22, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lifecore Biomedical, Inc. (NASDAQ: LFCR) between October 7, 2020 and March 19, 2024, both dates inclusive (the “Class Period”), of the important September 27,…
NEW YORK, Sept. 22, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of GitLab Inc. (NASDAQ: GTLB) between June 6, 2023 and March 4, 2024, both dates inclusive (the “Class Period”), of the important November 4, 2024 lead…
NEW YORK, Sept. 22, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardelyx, Inc. (NASDAQ: ARDX) between October 31, 2023 and July 1, 2024, both dates inclusive (the “Class Period”), of the important October 15, 2024 lead…
NEW YORK, Sept. 22, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Agenus Inc. (NASDAQ: AGEN) between January 23, 2023 and July 17, 2024, both dates inclusive (the “Class Period”), of the important November 5, 2024 lead…
NEW YORK, Sept. 22, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Paragon 28, Inc. (NYSE: FNA) resulting from allegations that Paragon 28 may have issued materially misleading…
SOUTH SAN FRANCISCO, Calif., Sept. 22, 2024 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that the company plans to issue a pre-market press release and…